Cite
Engineered biosynthesis of cyclic lipopeptide locillomycins in surrogate host Bacillus velezensis FZB42 and derivative strains enhance antibacterial activity.
MLA
Luo, Chuping, et al. “Engineered Biosynthesis of Cyclic Lipopeptide Locillomycins in Surrogate Host Bacillus Velezensis FZB42 and Derivative Strains Enhance Antibacterial Activity.” Applied Microbiology & Biotechnology, vol. 103, no. 11, June 2019, pp. 4467–81. EBSCOhost, https://doi.org/10.1007/s00253-019-09784-1.
APA
Luo, C., Chen, Y., Liu, X., Wang, X., Wang, X., Li, X., Zhao, Y., & Wei, L. (2019). Engineered biosynthesis of cyclic lipopeptide locillomycins in surrogate host Bacillus velezensis FZB42 and derivative strains enhance antibacterial activity. Applied Microbiology & Biotechnology, 103(11), 4467–4481. https://doi.org/10.1007/s00253-019-09784-1
Chicago
Luo, Chuping, Yongxing Chen, Xuehui Liu, Xiaohua Wang, Xiaoyu Wang, Xiangqian Li, Yuping Zhao, and Lihui Wei. 2019. “Engineered Biosynthesis of Cyclic Lipopeptide Locillomycins in Surrogate Host Bacillus Velezensis FZB42 and Derivative Strains Enhance Antibacterial Activity.” Applied Microbiology & Biotechnology 103 (11): 4467–81. doi:10.1007/s00253-019-09784-1.